You just read:

Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes

News provided by

Oramed Pharmaceuticals Inc.

Dec 20, 2013, 07:30 ET